Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation
2018 · Biomedicine & Pharmacotherapy · 48 citations
https://doi.org/10.1016/j.biopha.2018.09.086
J
Jingyu Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
835
Citations
17
h-index
25
i10-index
Jingyu Zhang is an academic researcher from Tianjin University of Technology and Education. The author has contributed to research in topics: MicroRNA in disease regulation & RNA modifications and cancer & Protein Degradation and Inhibitors. The author has an h-index of 17, co-authored 53 publications.
ORCID: 0000-0003-4820-577XPapers by this author
worksThe identification of age-associated cancer markers by an integrative analysis of dynamic DNA methylation changes
2016 · Scientific Reports · 28 citations
https://doi.org/10.1038/srep22722
Bisdemethoxycurcumin attenuates OVA‑induced food allergy by inhibiting the MAPK and NF‑κB signaling pathways
2022 · Experimental and Therapeutic Medicine · 13 citations
https://doi.org/10.3892/etm.2022.11328
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
2025 · Acta Pharmaceutica Sinica B · 5 citations
https://doi.org/10.1016/j.apsb.2025.01.021
Rational engineering of degradation tail-driven CELMoD–antibody conjugates for precision malignancy therapy
2025 · Acta Pharmaceutica Sinica B · 1 citations
https://doi.org/10.1016/j.apsb.2025.09.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat